Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SSR504734 HCl

Catalog No. T90597 Copy Product Info
Purity: 99.93%
😃Good
SSR504734 is an orally active, selective, and reversible inhibitor of human, rat, and mouse GlyT1 (IC50 = 18, 15, and 38 nM, respectively). SSR504734 exhibits activity in schizophrenia, anxiety, and depression models [1].

SSR504734 HCl

Copy Product Info
😃Good
Catalog No. T90597

SSR504734 is an orally active, selective, and reversible inhibitor of human, rat, and mouse GlyT1 (IC50 = 18, 15, and 38 nM, respectively). SSR504734 exhibits activity in schizophrenia, anxiety, and depression models [1].

SSR504734 HCl
Cas No. 615571-23-8
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$41In StockIn Stock
5 mg$98In StockIn Stock
10 mg$158In StockIn Stock
25 mg$286In StockIn Stock
50 mg$429In StockIn Stock
100 mg$592In StockIn Stock
1 mL x 10 mM (in DMSO)$117In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.93%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
SSR504734 is an orally active, selective, and reversible inhibitor of human, rat, and mouse GlyT1 (IC50 = 18, 15, and 38 nM, respectively). SSR504734 exhibits activity in schizophrenia, anxiety, and depression models [1].
Targets&IC50
GlyT1 (human):18 nM, GlyT1 (rat):15 nM
In vitro
SSR504734 (15 nM-86 μM; 10 min) inhibits the ex vivo uptake of glycine in human SK-N-MC and rat C6 cells, with IC50 values of 18 nM and 15 nM, respectively [1].
In vivo
SSR504734 (i.p. and p.o.; 1-100 mg/kg; once) demonstrates good oral bioavailability with ID50 values of 5.0 and 4.6 mg/kg for i.p. and p.o. treatments, respectively [1]. At 30 mg/kg (i.p.; once), it maintains approximately 80% inhibition of specific glycine uptake from 1 to 7 hours post-administration [1]. At 10 mg/kg (i.p.; once), it rapidly and significantly increases extracellular glycine levels in the prefrontal cortex of freely moving male Sprague-Dawley rats [1].
Chemical Properties
Molecular Weight433.30
FormulaC20H21Cl2F3N2O
Cas No.615571-23-8
SmilesCl.[H][C@]1(CCCCN1)[C@@H](NC(=O)c1cccc(c1Cl)C(F)(F)F)c1ccccc1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SSR504734 HCl | purchase SSR504734 HCl | SSR504734 HCl cost | order SSR504734 HCl | SSR504734 HCl chemical structure | SSR504734 HCl in vivo | SSR504734 HCl in vitro | SSR504734 HCl formula | SSR504734 HCl molecular weight